AzTrials
AzTrials

Suicide PreventionPhase 2GRITNCT07738445

Retreat-Based Program for Violence-Exposed Women Veterans

A Phase 2 study testing GRIT and GRI in people with Suicide Prevention, run by VA Office of Research and Development at 3 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Given their elevated risk for suicide and barriers to engaging in VHA healthcare, violence-exposed women Veterans represent a specialized population for which expansions to current VHA programming are needed. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Suicide Prevention
What is being tested?
GRIT and GRI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
3 sitesUnited States
Study dates
1 Dec 2026to 31 Aug 2028
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Experienced interpersonal violence as evidenced by endorsement of items 6, 7, 8, 9, or 11 from the Life Events Checklist for DSM-5®
  • Are willing and able to participate in a two overnight, three-day, retreat and complete pre- and post-retreat surveys
  • Are actively engaged in VHA mental healthcare (i.e., have a documented mental health visit with a VA provider within the last 90 days
  • Endorse some difficulties in social functioning as indicated by a score >2 on at least two items of the social functioning questionnaire
  • Ability to speak, read, and understand spoken English sufficiently well to complete the procedures of the study
  • Have access to a mobile phone or computer device that will enable participation in virtual video sessions

Who cannot join

  • Current suicidal thoughts and intent (using the Columbia Suicide Severity Rating Scale; C-SSRS, (i.e., endorses items 1, 2, and 4 or 5)
  • Diagnosis of alcohol or substance use dependence in medical record. In cases where alcohol or substance use is identified as problematic but not reaching the threshold for diagnosis of SUD dependence, additional consultation with mental health providers and chart review by the PI will be used to determine suitability for participation
  • Current psychosis or mania as indicated by electronic health records, or as identified during baseline administration of Quick SCID

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Jennifer M Primack, PhD MA contact

(401) 273-7100 ext. 13400

Jennifer.Primack@va.gov

Kimberly Marcolivio, MEd CCRP contact

(401) 273-7100 ext. 13464

Kimberly.Marcolivio@va.gov

United States3 sites
  • Providence VA Medical Center, Providence, RI

    Providence, Rhode Island, 02908-4734

    Kate J Barnabe, MHA, (401) 273-7100 ext. 16272, Kate.Barnabe@va.gov

    Kimberly Marcolivio, MEd CCRP, (401) 273-7100 ext. 13464, Kimberly.Marcolivio@va.gov

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut, 06516-2770

    Candice Presseau, PhD

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut, 06516-2770

    Candice Presseau, PhD, 203-223-8345, Candice.Presseau@va.gov

    Galina Portnoy, PhD, (203) 7023145, Galina.Portnoy@va.gov

Other trials in United States

About this study

Official title: A Pilot Study to Examine Acceptability and Feasibility of Growth, Resilience, Insight, and Togetherness (GRIT), a Retreat-Based Program for Violence-Exposed Women Veterans

Given their elevated risk for suicide and barriers to engaging in VHA healthcare, violence-exposed women Veterans represent a specialized population for which expansions to current VHA programming are needed. This pilot study is to assess the feasibility, acceptability, and preliminary efficacy of the Growth, Resilience, Insight, and Togetherness (GRIT), a therapeutic retreat program developed with and for Veteran women, to improve social functioning as a potential upstream suicide prevention strategy in comparison to a self-guided program. If found acceptable and feasible, data gathered will inform subsequent program development and identify avenues for further research on use of retreats grounded in Whole Health principles for additional subpopulations of women Veterans and/or other high-risk populations that may benefit.

Read the detailed description

Women Veterans are exposed to interpersonal violence at high rates throughout their lifespans which may escalate risk for psychosocial impairment and suicidal behavior. Facets of social functioning such as connectedness and social support can mitigate suicide risk. Given their risk for suicide and barriers to engaging in Veterans Administration (VHA) healthcare, violence-exposed women Veterans represent a specialized population for which expansion of VHA programming to include opportunities for socialization and community building as a key component of holistic health are needed. Coinciding with a congressional mandate for women-only retreat-based rehabilitation following military service, retreats are increasingly offered by community organizations. Retreats are associated with significant improvements in mental health and quality of life; however, no research to date has examined retreat programming as an upstream suicide prevention strategy for a high priority, high risk population of Veterans.

The primary aim of this multi-site, two-year, pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of "Growth, Resilience, Insight, and Togetherness" (GRIT), a retreat-based intervention designed for women Veterans who have experienced intimate partner violence (IPV). GRIT is a retreat-based program designed to enhance social functioning for women Veterans as an upstream suicide prevention strategy. Grounded in Whole Health principles, this holistic complementary program offered in a nature-based, tranquil setting was created for, and with input from, women Veterans known to be at heightened suicide risk due to experiences of interpersonal violence. Through participation in group activities, experiential learning, and envisioning and planning for the future post-retreat, GRIT seeks to combat loneliness and isolation while fostering connection to self and others to support longer term recovery from the sequelae of violence exposure(s).

Using a selective suicide prevention strategy, 48 women Veterans (N = 48) who have experienced interpersonal violence and endorse difficulties in at least two areas of social functioning will be recruited from two VA medical centers: VA Providence Healthcare system and VA Connecticut healthcare system. Eligible participants will be randomly assigned to the GRIT retreat or Growth, Resilience, and Insight (GRI), a self-guided version of the program that does not include a retreat. Participants will receive the GRIT in cohorts of approximately 12. Retreats will be co-led by pairs of VHA trained facilitators from VA Connecticut. A mixed methods approach will be used to evaluate feasibility and acceptability of GRIT and study procedures. Feasibility metrics will include ease of recruitment, program and study completion, and number of adverse events. Acceptability metrics will include participant ratings of satisfaction, credibility, perceived usefulness, and low burdensomeness of study procedures and GRIT/GRI programs. Preliminary efficacy data will be collected on social functioning and mental health impairment, and suicide risk pre-, post-, and two months following program completion.

Being tested
GRIT, GRI
Keywords
Loneliness, perceived social support
Medical subject headings
Suicide Prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GRITBehavioural

    3-day retreat conducted in person, in a group setting.

  • GRIBehavioural

    3-day self paced program. Conducted individually with group pre- and post-program sessions.

Study groups in NCT07738445
Study groupRoleWhat they receive
GRITExperimentalGRIT is a 3-day retreat-based program designed to enhance social functioning for women Veterans as an upstream suicide prevention strategy. The intervention includes an initial 90-minute group introduction session (approximately 7 days before the retreat) and a 90-minute group wrap up session (one week after completion of the retreat.
Receives: Behavioral: GRIT
GRIActive comparatorGRI is a self-guided version of the retreat-program which includes writing, psychoeducational videos, reflection, worksheets, and activity prompts along with pre-recorded mindfulness activities to complete during the same 3-day timeframe. GRI participants are similarly introduced to Whole Health personal health planning during the initial virtual session and guided toward completing a personal health inventory and setting personal health goals that are followed up on in the post-program virtual wrap-up session. GRI is self-guided over 3 days and participants complete the workbook but do not participate in the group retreat.
Receives: Behavioral: GRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility (study created metrics)

    Feasibility will be assessed by collecting information on the number of Veterans screened, enrolled, dropout rates, number of GRIT/GRI sessions completed. Determination of feasibility will be made by comparing the obtained metrics to the following metrics:

    • Recruit and enroll 12 participants per condition per year.
    • Dropout rate is < 25%
    • 75% of participants complete ≥75% each condition sessions

    Measured: 2 months

  2. Client Satisfaction Questionnaire

    An 8-item self-report measure assessing participants' satisfaction with services received. Items are rated on a 4-point Likert scale with higher scores indicating greater satisfaction with services.

    Measured: 2 months

  3. UCLA Loneliness scale

    A 20-item self-report measure assessing subjective feelings of loneliness and social isolation. Items are rated on 4-point Likert scale ranging from 1 to 4 with higher scores indicated greater loneliness

    Measured: 2 months

Secondary outcomes (3)
  1. Social Functioning Questionnaire

    The Social Functioning Questionnaire (SFQ) consists of 8 items designed to assess an individual's social functioning across various domains. Each item evaluates key aspects such as interpersonal relationships, work performance, and leisure activities through concise questions. Responses are measured on a 4-point Likert scale ranging from 0 (not at all) to 3 (most of the time), allowing for quantifiable assessment of social engagement and difficulties.

    Measured: 2 months

  2. Social Connectedness Scale, revised

    The Social Connectedness Scale - Revised (SCS-R) is a 20-item instrument designed to measure an individual's sense of connectedness and belonging within their social environment. The scale consists of 20 items rated on a 6-point Likert scale, where 1 indicates "strongly disagree" and 6 indicates "strongly agree." This allows for a nuanced understanding of an individual's feelings of connectedness. Scores are summed to yield a total score ranging from 20 to 120. A higher score reflects greater feelings of connectedness, while a lower score may indicate feelings of isolation or disconnection

    Measured: 2 months

  3. Thwarted belongingness subscale of the Interpersonal Needs Questionnaire

    This subscale is a self-report measure of perceived social disconnection, loneliness, and unmet need to belong. The subscale consists of 9 items rated on a 7-point Likert scale. Higher scores indicate greater thwarted belongingness.

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2026
  2. Study start1 Dec 2026 (estimated)
  3. Primary completion31 May 2028 (estimated)
  4. Study completion31 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Women Veterans will be randomized to either the GRIT retreat-based condition or GRI, a self-guided version of the program that does not include a retreat. Participants will be randomized using a computer-generated block randomization sequence into one of the two conditions, with 24 participants randomized to each group. Random block sizes of 4 and 6 will be used to maintain allocation balance while reducing predictability of assignment. Veteran participants will be assessed at baseline, during the intervention, post-intervention, 2-month follow up using a combination of self-report measures, interview-administered measures, and a semi-structured interview to obtain data on feasibility, acceptability, and preliminary efficacy.
Masking
None (open label)
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07738445
Sponsor's protocol ID
RRD4-001-25M
Other IDs
1I21RD000358-01A1
Acronym
GRIT
Status last verified
Jul 2026
First submitted
27 Jul 2026
Last updated
31 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing GRIT and GRI in people with Suicide Prevention, run by VA Office of Research and Development at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 31 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jennifer M Primack, PhD MA ((401) 273-7100 ext. 13400, Jennifer.Primack@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility (study created metrics) (time frame: 2 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in